Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706
- PMID: 40430107
- PMCID: PMC12112704
- DOI: 10.3390/ijms26104837
Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706
Abstract
In the original publication [...].
Erratum for
-
NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.Int J Mol Sci. 2023 Apr 22;24(9):7706. doi: 10.3390/ijms24097706. Int J Mol Sci. 2023. PMID: 37175412 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous